Literature DB >> 20887768

Haemolytic and cytotoxic action of latarcin Ltc2a.

Olga V Vorontsova1, Natalya S Egorova, Alexander S Arseniev, Alexey V Feofanov.   

Abstract

Activity and action mechanisms of latarcin 2a (Ltc2a), an antimicrobial peptide from the venom of the spider Lachesana tarabaevi (Zodariidae), were studied in vitro on human cells. Cytotoxicity of Ltc2a for erythrocytes (EC(50) = 3.4 μM), leukocytes (EC(50) = 19.5 μM) and erythroleukemia K562 cells (EC(50) = 3.3 μM) has been found to be primary related to plasma membrane destabilization. Using fluorescently labeled Ltc2a, three common features are found for erythrocytes and K562 cells: pronounced inhomogeneity of cellular response to Ltc2a; complex multistage character of Ltc2a-cell interactions; a positive feedback between Ltc2a binding to plasma membrane and development of toxic effects. Discocyte - echinocyte - spherocyte - ghost is a sequence of Ltc2a-induced transformations of erythrocytes that are accompanied by multistage enhancement of Ltc2a membrane binding, formation of small (ca. 2.0 nm) membrane pores, osmotic imbalance development and reorganization of the pores into large (ca. 13 nm) membrane openings that are preserved in ghosts. Ltc2a induces membrane blebbing and swelling of K562 cells followed by cell death. Cytotoxic action occurs through formation of membrane pores (ca. 3.7 nm) which show greater permeability for anionic than cationic molecules. The pore formation is accompanied with self-assisted Ltc2a internalization and accumulation in mitochondria, mitochondrion inactivation and apoptosis-independent phosphatidylserine externalization. Copyright Â
© 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20887768     DOI: 10.1016/j.biochi.2010.09.016

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

Review 1.  Latarcins: versatile spider venom peptides.

Authors:  Peter V Dubovskii; Alexander A Vassilevski; Sergey A Kozlov; Alexey V Feofanov; Eugene V Grishin; Roman G Efremov
Journal:  Cell Mol Life Sci       Date:  2015-08-19       Impact factor: 9.261

2.  Cyto-Insectotoxin 1a from Lachesana tarabaevi Spider Venom Inhibits Chlamydia trachomatis Infection.

Authors:  Nadezhda F Polina; Marina M Shkarupeta; Anna S Popenko; Alexander A Vassilevski; Sergey A Kozlov; Eugene V Grishin; Vassili N Lazarev; Vadim M Govorun
Journal:  Probiotics Antimicrob Proteins       Date:  2012-09       Impact factor: 4.609

3.  Phlogiellus bundokalbo spider venom: cytotoxic fractions against human lung adenocarcinoma (A549) cells.

Authors:  Anna Beatriz R Mayor; Leonardo A Guevarra; Myla R Santiago-Bautista; Librado A Santiago
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-08-03

Review 4.  Spider-venom peptides as therapeutics.

Authors:  Natalie J Saez; Sebastian Senff; Jonas E Jensen; Sing Yan Er; Volker Herzig; Lachlan D Rash; Glenn F King
Journal:  Toxins (Basel)       Date:  2010-12-20       Impact factor: 4.546

5.  First generation of multifunctional peptides derived from latarcin-3a from Lachesana tarabaevi spider toxin.

Authors:  Luiz Filipe Ramalho Nunes de Moraes; Patrícia Souza E Silva; Tábata Camila Pereira Leite Pereira; Thiago Antônio Almeida Rodrigues; Breno Emanuel Farias Frihling; Rosiane Andrade da Costa; Heron Fernandes Vieira Torquato; Cauê Santos Lima; Edgar Julian Paredes-Gamero; Ludovico Migliolo
Journal:  Front Microbiol       Date:  2022-09-21       Impact factor: 6.064

6.  A new theraphosid spider toxin causes early insect cell death by necrosis when expressed in vitro during recombinant baculovirus infection.

Authors:  Daniel Mendes Pereira Ardisson-Araújo; Fabrício Da Silva Morgado; Elisabeth Ferroni Schwartz; Gerardo Corzo; Bergmann Morais Ribeiro
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.